Publikationen, an denen er mitarbeitet Francisco Javier Gómez-Ulla de Irazazábal (1)

2022

  1. Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials

    The Lancet, Vol. 399, Núm. 10326, pp. 741-755